About Sonke Pharmaceuticals
Sonke Pharmaceuticals (Pty) Ltd was established in January 2006 as a Black Economic Empowerment joint venture between Ranbaxy (Pty) Ltd and Community Investment Holdings.
Sonke Pharmaceuticals has launched 21 products to date, nine of which are manufactured locally in South Africa. We are committed to acting responsibly in all economic, social and environmental aspects of our business.
Our people are an important part of our success. At Sonke Pharmaceuticals, we place a high premium on the personal well-being of our directors, management and support staff. We have created and continuously strive to maintain a professional and creative working environment where personnel feel welcome and appreciated for their efforts and contribution.
A level 5 B-BBEE Empowerdex BEE Contributor-Rating with majority staff qualifying as Historically Disadvantaged Individuals confirms our commitment to transformation and empowerment.
Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies.
Ranbaxy’s continued focus on R&D has resulted in several approvals in developed markets and significant progress in New Drug Discovery Research. The Company’s foray into Novel Drug Delivery Systems has led to proprietary "platform technologies," resulting in a number of products under development.
The Company is serving its customers in over 125 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 46 countries and manufacturing operations in 7 countries. Ranbaxy is a member of the Daiichi Sankyo Group. Daiichi Sankyo is a leading global pharma innovator, headquartered in Tokyo, Japan.